Equity Research, Broker Reports, and media content on Shield Therapeutics

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Shield Therapeutics
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Shield Therapeutics. We currently have 73 research reports from 7 professional analysts.

Open
N/A
Range Today
N/A
52 Week
30.5/120p
Daily Volume
N/A
# Shares
117.2m
Daily Liquidity
(0.10%)
Pension Liability
£0m
Enterprise Value
£78.1m
Market Cap
£123.6m
Latest PE (hist)
Div Yield
Date Source Announcement
02Jul19 12:00 RNS Additional Listing
13Jun19 14:16 RNS Result of AGM
03Jun19 07:00 RNS Update on Legal Proceedings
13May19 12:00 EQS Hardman & Co Research: Shield Therapeutics (STX): All in the execution
08May19 07:00 RNS Appointment of Joint Broker
02May19 07:00 RNS-R Investor presentation
01May19 11:58 RNS Additional Listing
  • Frequency of research reports

     

  • Research reports on

    Shield Therapeutics

  • Providers covering

    Shield Therapeutics